Tangier disease: epidemiology, pathophysiology, and management. - Test2 - elhamkhani - TriplyDB

Tangier disease: epidemiology, pathophysiology, and management.

Tangier disease: epidemiology, pathophysiology, and management.

http://www.wikidata.org/entity/Q33402921

about

Cervical lymph node diseases in children Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation.Impact of cholesterol on disease progression An uncommon cause of bifacial weakness and non-length-dependent demyelinating neuropathy.Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation.ATP-binding cassette transporter A1: from metabolism to neurodegeneration.Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.Systemic associations of corneal deposits: a review and photographic guide.

P2860

Q26865114-03A0812B-2B45-415F-8534-C25EB2DCC208 Q27690256-701D59BB-CA21-4C5D-8267-DBC1D8FFEAF9 Q30380038-E7B18D91-C00A-4665-BF31-239532465FDE Q34544856-08E37985-8521-4EF6-8F40-339D5DF4375F Q35850911-1DED54EB-D6B5-407B-B905-3EAD3FDBE344 Q36383801-2E9E1856-9BF1-4EBF-A7DE-0C2BFFA1794C Q36662860-23B9325B-D843-41BC-8A80-FACE60C903B1 Q37671430-8C301777-F30A-4CAF-A054-D8891FF9EFAD Q38213077-61BA405A-0156-4D6B-A085-95CB9CDFC1E3 Q38866973-DBC4F8BA-94F0-48F8-8FC4-659D659417F0 Q38867444-598E94FE-CC9D-4AEF-B36A-0E2C302A92BE

P2860

Tangier disease: epidemiology, pathophysiology, and management.

http://www.wikidata.org/entity/Q33402921

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Tangier disease: epidemiology, pathophysiology, and management.

@ast

Tangier disease: epidemiology, pathophysiology, and management.

@en

type

label

Tangier disease: epidemiology, pathophysiology, and management.

@ast

Tangier disease: epidemiology, pathophysiology, and management.

@en

prefLabel

Tangier disease: epidemiology, pathophysiology, and management.

@ast

Tangier disease: epidemiology, pathophysiology, and management.

@en

P1433

Q33402921-8EEC573F-808D-4CE5-8D0E-482F21EC58B2

P1476

Q33402921-E0C3F241-90F6-4D7E-9348-FC809F5D0549

P2093

Q33402921-4B755950-35B5-49B4-ACE1-D75C5FCE458B

Q33402921-52484AAF-9ECE-4F9E-84EF-2CA3496E4C3E

Q33402921-99A56DBF-BEC4-42EE-85DC-392FE8A69A9C

Q33402921-C7FCE34E-DF63-44F4-B29E-1968B2555E47

P2860

Q33402921-071B3F23-1336-483C-BAEF-7FAD713AF653

Q33402921-0849B9ED-F70B-4B17-BBDB-3CA79B095720

Q33402921-170094C1-A7C9-4F7A-809A-2530E1F01DC5

Q33402921-17502DA1-8605-4BF0-B304-FFD13FF8E7B1

Q33402921-1826B0FD-2E15-422F-87B8-276829031E2C

Q33402921-1BBA99DE-B301-49D3-BAD3-2087BFD3E152

Q33402921-29CC9FC2-5FFE-455D-BE4C-E8FE5768988B

Q33402921-341AFAB5-C493-4AA7-9FF0-48FF45AAA0D8

Q33402921-4A01D39C-EA63-4DEF-A9CC-F642C39E60CA

Q33402921-4E652938-2D77-4509-BAA7-148B11A3F02C

P2888

Q33402921-7B37DD00-E110-4CE6-9514-843132119837

P304

Q33402921-B7879C77-1B2C-4A29-A552-781EBFBAB071

P31

Q33402921-868FA31C-C2A9-4B2E-B990-AFB938C05051

P356

Q33402921-F8C6C76E-F521-4EEF-9F74-573332F13064

P433

Q33402921-5DC5C031-3EAF-4E39-9948-3D4A9D222B9E

P478

Q33402921-E18251D4-B1FC-40AD-B5B2-2B2F77D04F3C

P577

Q33402921-F0991838-263D-41A4-AA31-42647292FCBC

P6179

Q33402921-4B7CC9E1-3657-406E-9213-150E1CD28FF6

P698

Q33402921-727F1DA8-1CF5-400D-AAEE-496691818582

P921

Q33402921-B566D996-8F5D-4E16-914E-713F9A5164E3

P356

P1433

American journal of cardiovascular drugs

P1476

Tangier disease: epidemiology, pathophysiology, and management.

@en

P2093

Federico Bigazzi

http://www.w3.org/2001/XMLSchema#string

Francesco Sbrana

http://www.w3.org/2001/XMLSchema#string

Mariarita Puntoni

http://www.w3.org/2001/XMLSchema#string

Tiziana Sampietro

http://www.w3.org/2001/XMLSchema#string

P2860

Study of ABCA1 function in transgenic mice

Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis

Tangier disease: still more questions than answers

A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency.

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis.

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.

P2888

P304

303-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03261839

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026483530

http://www.w3.org/2001/XMLSchema#string

P698

22913675

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology